Abstract
IntroductionCognitive behavioural therapy for psychosis (CBTp) has demonstrated effectiveness in reducing positive symptoms, improving depression, enhancing coping skills and increasing awareness of illness. However, compared with cognitive behavioural therapy for depression and anxiety, the spread of CBTp in clinical practice is minimal. The present study designed a randomised controlled trial (RCT) research protocol to evaluate whether real-time remote video-conference CBTp (vCBTp) could facilitate access to psychosocial interventions and effectively improve symptoms compared with usual care (UC) for patients with schizophrenia.Methods and analysisThis exploratory RCT will consist of two parallel groups (vCBTp+UC and UC alone) of 12 participants (n=24) diagnosed with schizophrenia, schizoaffective disorder or paranoid disorder, who remain symptomatic following pharmacotherapy. Seven 50-min weekly vCBTp interventions will be administered to test efficacy. The primary outcome will be the positive and negative syndrome scale score at week 8. The secondary outcome will be the Beck Cognitive Insight Scale to assess insight, the Patient Health Questionnaire-9 to assess depression, the Generalised Anxiety Disorder-7 to assess anxiety, the 5-level EuroQol 5-dimensional questionnaire to assess quality of life and the Impact of Event Scale-Revised to assess subjective distress about a specific stressful life event. We will take all measurements at 0 weeks (baseline) and at 8 weeks (post-intervention), and apply intention-to-treat analysis.Ethics and disseminationWe will conduct this study in the outpatient department of Cognitive Behavioral Therapy Center at Chiba University Hospital. Further, all participants will be informed of the study and will be asked to sign consent forms. We will report according to the Consolidated Standards of Reporting Trials.Trial registration numberUMIN000043396.
Funder
Grant-in-Aid for Scientific Research
Reference46 articles.
1. Excess Early Mortality in Schizophrenia
2. Saha S , Chant D , Welham J , et al . A systematic review of the prevalence of schizophrenia. PLoS Med 2005;2:e141. doi:10.1371/journal.pmed.0020141
3. Schizophrenia
4. Direct healthcare cost of schizophrenia - European overview;Kovács;Eur Psychiatry,2018
5. National Institute for Health and Care Excellence (NICE) . Psychosis and schizophrenia in adults: prevention and management. London: National Institute for Health and Care Excellence, Available: http://www.ncbi.nlm.nih.gov/books/NBK555203/